カテゴリー： QYResearch, 世界

世界の高性能医薬品有効成分(HPAPI)市場

◆英語タイトル：Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Professional Survey Report 2019
◆商品コード：DATA909X09035
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、高性能医薬品有効成分(HPAPI)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、合成成分、生物学的成分、その他に、用途別には、腫瘍学、緑内障、抗糖尿病、心血管、筋骨格、ホルモン、その他にセグメント区分し、高性能医薬品有効成分(HPAPI)の世界市場を分析しました。

・エグゼクティブ・サマリー
・高性能医薬品有効成分(HPAPI)の世界市場概要
・高性能医薬品有効成分(HPAPI)の製造コスト構成分析
・高性能医薬品有効成分(HPAPI)の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・高性能医薬品有効成分(HPAPI)の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・高性能医薬品有効成分(HPAPI)のセグメント分析（種類別）
（合成成分、生物学的成分、その他）
・高性能医薬品有効成分(HPAPI)のセグメント分析（用途別）
（腫瘍学、緑内障、抗糖尿病、心血管、筋骨格、ホルモン、その他）
・高性能医薬品有効成分(HPAPI)の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bristol-Myers Squibb、Novartis、Sanofi Aventis、Pfizer、Lonza、Novasep、Hospira、BASF、Merck、Bayer、Teva Pharmaceuticals、Boehringer Ingelheim、）
・高性能医薬品有効成分(HPAPI)の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global High Performance Active Pharmaceutical Ingredients (HPAPI) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on High Performance Active Pharmaceutical Ingredients (HPAPI) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Performance Active Pharmaceutical Ingredients (HPAPI) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of High Performance Active Pharmaceutical Ingredients (HPAPI) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their High Performance Active Pharmaceutical Ingredients (HPAPI) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bristol-Myers Squibb
Novartis
Sanofi Aventis
Pfizer
Lonza
Novasep
Hospira
BASF
Merck
Bayer
Teva Pharmaceuticals
Boehringer Ingelheim

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Synthetic Ingredients
Biological Ingredients
Others

Segment by Application
Oncology
Glaucoma
Anti-diabetic
Cardiovascular
Musculoskeletal
Hormonal
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of High Performance Active Pharmaceutical Ingredients (HPAPI)
1.1 Definition of High Performance Active Pharmaceutical Ingredients (HPAPI)
1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Type
1.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Synthetic Ingredients
1.2.3 Biological Ingredients
1.2.4 Others
1.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Applications
1.3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Glaucoma
1.3.4 Anti-diabetic
1.3.5 Cardiovascular
1.3.6 Musculoskeletal
1.3.7 Hormonal
1.3.8 Others
1.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Overall Market
1.4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (2014-2025)
1.4.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (2014-2025)
1.4.3 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.5 China High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.6 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.7 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)
1.4.8 India High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
2.3 Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
2.4 Industry Chain Structure of High Performance Active Pharmaceutical Ingredients (HPAPI)

3 Development and Manufacturing Plants Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
3.1 Capacity and Commercial Production Date
3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of High Performance Active Pharmaceutical Ingredients (HPAPI)
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Production and Capacity Analysis
4.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Analysis
4.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Price Analysis
4.4 Market Concentration Degree

5 High Performance Active Pharmaceutical Ingredients (HPAPI) Regional Market Analysis
5.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Regions
5.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Regions
5.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Regions
5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Regions
5.3 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.3.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.3.2 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.4.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.4.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.5 China High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.5.1 China High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.5.2 China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.6 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.6.1 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.6.2 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.7 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.7.1 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.7.2 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export
5.8 India High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis
5.8.1 India High Performance Active Pharmaceutical Ingredients (HPAPI) Production
5.8.2 India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India High Performance Active Pharmaceutical Ingredients (HPAPI) Import and Export

6 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment Market Analysis (by Type)
6.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Type
6.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Type
6.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Price by Type

7 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment Market Analysis (by Application)
7.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Application
7.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Application (2014-2019)

8 High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers Analysis
8.1 Bristol-Myers Squibb
8.1.1 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.1.3 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi Aventis
8.3.1 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.3.2 Sanofi Aventis Product Introduction, Application and Specification
8.3.3 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Lonza
8.5.1 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.5.2 Lonza Product Introduction, Application and Specification
8.5.3 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novasep
8.6.1 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.6.2 Novasep Product Introduction, Application and Specification
8.6.3 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Hospira
8.7.1 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.7.2 Hospira Product Introduction, Application and Specification
8.7.3 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 BASF
8.8.1 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.8.2 BASF Product Introduction, Application and Specification
8.8.3 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Merck
8.9.1 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.9.2 Merck Product Introduction, Application and Specification
8.9.3 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Bayer
8.10.1 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
8.10.2 Bayer Product Introduction, Application and Specification
8.10.3 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Teva Pharmaceuticals
8.12 Boehringer Ingelheim

9 Development Trend of Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI) Market
9.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Trend Analysis
9.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Volume and Value) Forecast 2019-2025
9.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Regional Market Trend
9.2.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.5 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.2.6 India High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast 2019-2025
9.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Trend (Product Type)
9.4 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of High Performance Active Pharmaceutical Ingredients (HPAPI)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Types in 2018
Figure Synthetic Ingredients Product Picture
Figure Biological Ingredients Product Picture
Figure Others Product Picture
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Applications in 2018
Figure Oncology
Figure Glaucoma
Figure Anti-diabetic
Figure Cardiovascular
Figure Musculoskeletal
Figure Hormonal
Figure Others
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) (2014-2025)
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) (2014-2025)
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) (2014-2025)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI) in 2018
Figure Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)
Figure Industry Chain Structure of High Performance Active Pharmaceutical Ingredients (HPAPI)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Plants Distribution
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity (K MT) of Major Manufacturers (2014-2019)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) of Major Manufacturers (2014-2019)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share of Major Manufacturers (2014-2019)
Figure High Performance Active Pharmaceutical Ingredients (HPAPI) Production Share by Manufacturers in 2018
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share of Major Manufacturers (2014-2019)
Figure High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Manufacturers in 2018
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production by Regions 2014-2019 (K MT)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Regions 2014-2019
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Regions in 2018
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Regions 2014-2019 (Million USD)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Regions 2014-2019
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Regions in 2018
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Regions 2014-2019 (K MT)
Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Regions 2014-2019
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate 2014-2019 (K MT)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2014-2019 (Million USD)
Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption Import and Export (K MT)
Figure Global Consumption High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2014-2019)
Figure Global Value (Consumption) High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction, Application and Specification
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2014-2019)
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2014-2019)
Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2014-2019)
Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Main Business and Markets Served
Table Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Table Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Production Sites and Area Served
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production (K MT) Growth Rate Forecast 2019-2025
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Forecast 2019-2025
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate Forecast 2019-2025 (K MT)
Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of High Performance Active Pharmaceutical Ingredients (HPAPI) by Type (2019-2025)
Table Global Consumption (K MT) of High Performance Active Pharmaceutical Ingredients (HPAPI) by Application (2019-2025)
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Distributors List
Table High Performance Active Pharmaceutical Ingredients (HPAPI) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Bristol-Myers Squibb、Novartis、Sanofi Aventis、Pfizer、Lonza、Novasep、Hospira、BASF、Merck、Bayer、Teva Pharmaceuticals、Boehringer Ingelheim、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の高性能医薬品有効成分(HPAPI)市場(Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp